Kindred Biosciences, Inc (KIN) Covered Calls

Kindred Biosciences Inc is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. The Company's product candidates are SentiKind, KIND-010 and KIND-012.

You can sell covered calls on Kindred Biosciences, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for KIN (prices last updated Fri 4:16 PM ET):

Kindred Biosciences, Inc (KIN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
8.40 -0.27 8.08 8.79 281K -6.8 0.3B
Covered Calls For Kindred Biosciences, Inc (KIN)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jun 21 7.5 0.10 8.69 -13.7% -138.9%
Jul 19 7.5 0.25 8.54 -12.2% -69.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. Its product candidates are cerekin for the treatment of osteoarthritis pain and inflammation in dogs; atokin for the treatment of atopic dermatitis in dogs; and sentikin for the treatment of post-operative pain in dogs. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.